Covariate and confounder selection in case-control studies is most commonly carried out using either a two-step method or a stepwise variable selection method in logistic regression. Inference is then carried out conditionally on the selected model, but this ignores the model uncertainty implicit in the variable selection process, and so underestimates uncertainty about relative risks. We report on a simulation study designed to be similar to actual case-control studies. This shows that p-values computed after variable selection can greatly overstate the strength of conclusions. For example, for our simulated case-control studies with 1,000 subjects, of variables declared to be \signi cant" with p-values between .01 and .05, only 49% actually were risk factors when stepwise variable selection was used.
Introduction
Case-control studies ( 1] , 2]) represent a high proportion of epidemiological practice. For example, at least 49 such studies were published in the American Journal of Epidemiology alone in 1996 (see below).
The aim of case-control studies is to test the existence of possible risk factors of interest, and to estimate their association with the presence or absence of a disease, after adjusting for possible confounders. A sample of n 1 cases and n 2 controls is taken, where often n 2 is roughly an integer multiple of n 1 (n 1 n 2 is common). Although the sample is drawn based on the disease outcome, the sampling plan is much more e cient than random sampling. Remarkably, consistent and near-optimal estimates of adjusted relative risks can be obtained if the model used is logistic regression, namely log Pr (Y =1) Pr(Y =0) = 0 + 1 X 1 + 2 X 2 + : : : + q X q ; (1) where Y is 1 if the disease is present and 0 if it is absent, X 1 is a dichotomous risk factor of interest, X 2 ; : : : ; X q are confounders, and 0 ; 1 ; : : : ; q are regression parameters. An attraction of this model is that the adjusted relative risk, exp( 1 ), is the same for all values of the confounders, and does not involve any coe cients other than 1 . This greatly facilitates reporting and interpretation of the results. This adjusted relative risk can be approximated by the odds ratio, namely Odds(Y = 1jX 1 = 1; X 2 ; : : : ; X q ) Odds(Y = 1jX 1 = 0; X 2 ; : : : ; X q ) ; (2) where Odds = Probability/(1?Probability). The choice of the confounders, X 2 ; : : : ; X q , to include is a major issue. In most studies, the potential confounders are numerous, including demographic, socioeconomic, familial disease history, smoking and other lifestyle variables, as well as medical measurements; often something like 20 to 50 such variables are initially considered. It is vital not to omit important confounders, which would point towards including all confounders considered, but doing so tends to lead to ine cient estimation, both in theory (e.g. 3], chap. 9) and in practice 4]. Thus, investigators have tended to use statistical methods to choose among the many confounders indicated by substantive considerations. The two most commonly used methods are a two-stage method 4] and backwards stepwise regression; both of these are described, for example, in the in uential textbook 5] .
Investigators typically carry out tests and compute con dence intervals 6] conditionally on the selected logistic regression model, without taking account of the fact that variable selection has been done. It has been shown, particularly in the linear regression context, that doing this can yield misleading results, often tending to reject null hypotheses more often than the nominal levels would suggest, and to produce con dence intervals that are too narrow (e.g. 7 
], 8]).
Here we present a method, Bayesian model averaging, that provides a formal way of taking account of this uncertainty in both tests and con dence intervals. We carry out a simulation study designed to be representative of actual case-control studies, and show that p-values computed after two-stage or stepwise variable selection can be quite misleading, while the posterior probabilities from Bayesian model averaging achieve roughly their nominal error rates. In addition, Bayesian model averaging point estimates of adjusted relative risks are more accurate on average than those from the variable selection methods. We illustrate the method with an application to a case-control study investigating risk factors for cervical cancer 9].
MATERIALS AND METHODS

Bayesian Model Averaging
General Principles
Bayesian model averaging (BMA) is the Bayesian solution to the problem of inference in the presence of multiple competing models ( 10] BMA starts by acknowledging that in the situation of equation (1) there are up to K = 2 q possible models (assuming that no interaction exists between the risk factors) de ned by allowing each of X 1 ; : : : ; X q to be either in or out of the model. We denote these models by M 1 ; : : : ; M K . We do not know in advance which of these is the best model, and so there is model uncertainty. BMA simply propagates this uncertainty through to inference about any quantity of interest in the same way as the Bayesian approach propagates any other form of uncertainty. This is done using the law of total probability, i.e. by summing or integrating over the quantities that are not of primary interest and about which there is uncertainty.
Suppose that Q is a quantity of interest, which here is an adjusted relative risk, but could also be a future observation, or the utility of a course of action. Its posterior distribution, taking account of model uncertainty, is (3) where D denotes the data at hand (here, observations on disease, risk factors and confounders), p(QjD; M k ) is the posterior distribution of Q under model M k , and p(M k jD) is the posterior probability of model M k given the data. Thus the overall posterior distribution of Q is a weighted average, or mixture, of its model-speci c posterior distributions, where the weights are the posterior model probabilities.
The posterior model probability, p(M k jD), of model M k given the data, is given by
where the constant of proportionality is chosen so that the posterior model probabilities add up to one. In equation (4), p(M k ) is the prior model probability of model M k ; these are often chosen to be equal so as not to favor one model over another a priori. The quantity p(DjM k ) is the integrated likelihood of model M k , which follows again from the law of total probability as the multiple integral
where k is the vector of regression parameters for model M k , p(Dj k ; M k ) is its (ordinary) likelihood, and p( k jM k ) is its prior distribution, both under model M k . Equation (5) poses two problems. The rst is the evaluation of the integral, which does not usually have an analytic form and can be of high dimension. Fortunately, for logistic regression, and indeed for generalized linear models more broadly, an accurate and quite tractable approximation is available using the Laplace method 15]. This can be implemented, and BMA carried out for logistic regression, using the glib software, which runs under S-PLUS and is available on the Web at www.research.att.com/~volinsky/software/glib, or at lib.statlib.cmu.edu/S/glib. The second problem is the choice of the prior distribution of the parameters, k . A prior distribution in which each of the k j is independent and normal, with mean zero for all the parameters except the intercept, and with a prior standard deviation equal to a common scale parameter, , divided by the standard deviation of X j if X j is continuous, seems capable of representing a reasonable range of prior distributions while requiring the speci cation of only a single prior parameter, 15]. We will discuss the choice of below.
BMA has three appealing theoretical long-run properties. First, for the prediction of new observations, it gives better predictive performance on average (using a log score to measure performance), than any single model that could reasonably have been selected 11]. Second, inferences are well calibrated in the sense that, for example, con dence intervals have the right coverage on average 21]. The third property relates to Bayesian hypothesis testing using Bayes factors, when the null model is rejected against an alternative if it has lower posterior model probability. This test has lower total error rate (i.e. sum of Type I and Type II error rates) than any other test on average over the models and the prior distributions ( 22] , p. 396), and hence can be viewed as an automatic way of choosing a signi cance level so as to optimally balance power and signi cance.
This general approach has been used in several previous analyses of medical and epidemiological data. Racine et al 23] showed how this method may be used to make inference about a treatment e ect in the presence of uncertainty about the existence of a carryover e ect. An epidemiological study of fat and alcohol consumption as risk factors for breast cancer 24] was reanalyzed using Bayesian model averaging 25].
Similar analyses of coronary heart dise ase risk factors and the diagnosis of scrotal swellings have been reported 11]. In their examples, the authors found that out-of-sample predictive performance was better if one took account of model uncertainty than if one conditioned on any single model that might reasonably have been selected.
BMA Inference for an Adjusted Relative Risk
BMA provides hypothesis tests, point estimates and con dence intervals for an adjusted relative risk, all of which take account of model uncertainty.
For hypothesis testing, from a Bayesian point of view, the question becomes \what is the posterior probability that X 1 is a risk factor, i.e. that 1 , the adjusted log relative risk, is not equal to zero?" This is simply (6) Conventional rules of thumb for interpreting this quantity verbally are that if Pr 1 6 = 0jD] is less than 50%, there is no evidence for X 1 being a risk factor, if it is between 50% and 75% there is weak evidence for X 1 being a risk factor, if it is between 75% and 95% there is positive evidence, between 95% and 99% the evidence is strong, and beyond 99% the evidence is very strong ( 22] , Appendix B; 13]).
A Bayesian point estimate of 1 is its posterior mean, given that X 1 is in the model, namely Inference about 1 , including testing, point estimation and con dence intervals, is summarized by equations (6), (7) and (8) . A di culty is that each of these equations involves summation over all K = 2 q possible models, and K will often be impracticably large. For example, in the application we present later, q = 35, and so K could be as large as 2 35 , which is about 34 billion. To get around this, we approximate the full sum by excluding models that are far less probable a posteriori than the best model; here we adopt the convention of excluding models whose posterior probability is less than one-twentieth of that of the best model. This device, known as Occam's window 11], reduces the number of models enormously but still seems to provide a good approximation to the full sum 26]. There are also scienti c arguments supporting its use in its own right, and not just as an approximation 11]. The models in Occam's window can be found rapidly using a generalization of the leaps and bounds algorithm ( 27] , 12], 28]). Details are given in Appendix.
The BMA approach requires the speci cation of some prior quantities: -the prior probabilities P (M k ) of the models, which will be taken to be equal, so as not to favor any model a priori, and -the prior distribution of the parameters i . As suggested in 15] for the case of weak prior information, we assume that the distribution of is a centered Gaussian with a standard deviation to be speci ed.
To choose a value of , we noted that e i is the odds ratio (OR) corresponding to exposure to a dichotomous X i . Hence a choice of can be translated into probability statements relating to the distribution of typical OR's. We chose so that the prior probability of nding an OR greater than 7 will be less than 5 %. This was motivated by the shared expectation, based on our own experience and on discussions with epidemiologists at INSERM, that most OR investigated in case-control studies will be less than 7. This is in part because stronger associations will often already have been identi ed, and with strong associations interest is more likely to focus on the strength of the association rather than its existence, with doseresponse or other speci cally designed studies. Our choice was reinforced by consideration of the range of OR's found in our review of case-control studies published in 1996 (see the next sections and Table 1 ). Note that this prior choice can be easily modi ed by simply changing the value of .
Standard Methods
The di culties of variable selection techniques have been discussed by many authors ( 29] , 30], 31], 1], 5]). In order to characterize variable selection approaches commonly used for logistic regression in epidemiology, we reviewed the case-control studies published in the American Journal of Epidemiology in 1996, as well as the recent methodological literature. The results of case-control studies published in the American Journal of Epidemiology in 1996 were usually presented in terms of just one single model: the choice of this single nal model corresponds most of the time to a complex mixture of statistical and epidemiological arguments. We cannot model the full range of epidemiological considerations which in uence the choice of the nal model. We will oversimplify this procedure by considering the choice of models to be based only on signi cance level criteria, in two \classical" strategies.
The Two-Step Procedure
This procedure, described in 5], has been considered and examined in 4] as a possible strategy to identify confounders. A rst step of selection is carried out by univariate logistic regression. In a second step, each variable with a p-value in the rst stage less than a threshold, is retained for inclusion in a subsequent multiple logistic regression. The threshold is frequently taken as = :20. The associations interpreted are essentially those corresponding to variables having p-values less than = :05 in the second stage.
Stepwise Backwards Selection
In this strategy, all the variables are included in the rst model, then some are eliminated in a stepwise manner. One iteration of the procedure consists of the evaluation of the pvalue of each variable in a multiple logistic regression, and the elimination of the variable which has the highest p-value. The process stops when the p-values corresponding to all the remaining variables are less than .05, or some other threshold. The coe cients of the remaining variables are then re-estimated in this model.
Design of the Simulation Study 2.3.1 Basis for the Simulation Study Design: The Case-Control Studies in AJE, 1996
Determining a few cases of \typical" datasets to be simulated and analyzed is a delicate task and we have based our choice on a review of case-control studies published in the American Journal of Epidemiology in 1996. We have selected 49 case-control studies, which are used essentially as providing useful guidelines for the design of our simulation study. Most of the studies were conducted to establish the link between a speci c set of variables and a health outcome, or to evaluate the strength of the association for a variable already established as a risk factor. In this case, many other variables are entered in the multiple logistic regression as potential confounders. Other studies were more exploratory in nature and included a substantial number of variables, all considered to be potential risk factors.
In the setup of our simulation study, we have not focused on a particular variable, but have considered them all symmetrically.
The 49 selected studies had numbers of subjects ranging from 118 to 9,913, with a median of 894. We chose two di erent cases, each representative of substantial numbers of published studies : \Simulation 1" includes 300 subjects, and \Simulation 2," 1,000. In most studies, the number of controls was close to the number of cases and we chose equal numbers of cases and controls in each of the two simulation designs.
The Variables
The total number of variables initially considered is rarely fully reported in the articles. Indeed, the focus on one particular variable, or simply the need to summarize the results, often leads to the presentation of a small number of tables, including only some of the variables mentioned in the \Data Collection" paragraph. In the 49 studies, the total number of variables examined in the tables was between 3 and 39, with a mean of 16. This is likely to be an underestimate, due partly to the fact that the tables presented in a published study are a summary of the analysis itself and therefore frequently do not include all the variables examined, especially in the case where a particular risk factor is of prime interest. A detailed examination of the 49 studies, with special attention to the ones where variables were considered symmetrically as potential risk factors, led us to choose q = 32, which is also close to the number of variables in the cervical cancer study that we reanalyze later.
The number of variables actually associated with the health outcome, ideally corresponding to the typical dimension of a \ nal model" found in case-control studies, was chosen as 10, again based on our review of the published studies. We split this group into a subgroup of ve variables correlated with each other and ve others independent of each other. Among the 22 remaining variables which are not linked to the health outcome, some are also correlated with each other. This is aimed to encompass typical classes of \explanatory" variables recorded in epidemiological studies.
Before being entered in a logistic regression, the variables are almost always categorized or dichotomized. This is also the choice in our two simulations : independent variables were Bernoulli, while the variables correlated with each other were simulated as centered multivariate normal with all correlations equal to 0.4, then dichotomized. The frequency of exposure to the risk factors has been set at 20%, which is, for example, the approximate frequency of exposure to solvents in the general population, and seems reasonable to mimic the frequency of exposure in many case-control studies.
In order to choose the values of the logistic coe cients i , we have listed the OR of the variables of interest in the 49 studies selected: we considered the value(s) quoted in the summary when there were any, and if not, we took the estimated OR's corresponding to the risk factor investigated from the most complete model. Some OR's came from a univariate logistic regression, but most of them came from a multivariate model. Because of an obvious reversibility, we decided not to consider the case of protective factors and simply inverted their coe cients. Table 1 shows the distribution of the estimated OR, separately for the smaller and larger studies, with 200{400 and 700{1300 subjects respectively. The observed ORs were higher in the smaller studies. This is not unexpected as smaller studies have the power to detect only stronger associations. Correspondingly, we chose di erent coe cients i in the two simulated cases, with odds ratios in the interval 1.6-5.5] for Simulation 1, and in the interval 1.3-3.0] for Simulation 2. The outcome variables were simulated using the model in equation (1), where 0 was adjusted so as to yield a number of controls almost equal to the number of cases ( 0 = ?2 in Simulation 1, and 0 = ?1:5 in Simulation 2). For each simulation setup, 200 datasets were generated. Table 2 summarizes the design choices.
RESULTS
We analyzed our simulated data sets using the two \classical" methods and Bayesian model averaging. For the classical analyses, we recorded the p-values in the \ nal single model" when X i was listed among the selected variables. When X i did not appear in the nal model, we proceeded di erently for the two methods. If X i had been excluded in the rst step of the two-step procedure, we kept the p-value from this previous univariate analysis. If X i had been excluded during the stepwise process, we kept its p-value in the last model in which X i gured among the variables. In the Bayesian approach, we simply recorded the posterior probability that X i is associated with Y, Pr( i 6 = 0jD), from equation (6).
Posterior Probabilities and p-Values
We rst compare the observed and nominal performances of the methods. We thus consider the p-value associated with a coe cient for the classical methods, and the Pr( i 6 = 0jD) Tables 3 and 4 ). This number corresponds to variables that are declared by the method to be associated with Y at the given signi cance level. Then we calculated the proportion of these variables which are actually associated by design. This ratio gures in columns 3 and 5 of Tables 3 and 4 and gives the observed proportion of explanatory variables declared associated with this level of con dence which were actually associated with Y in our simulation. As an example, consider Simulation 2, the two-step analysis, and the 0.01-0.05] interval. If the p-value for a coe cient was less than .05 but greater than .01 (i.e. \signi cant"), how likely was it that the corresponding variable was actually associated with the outcome in the situation we simulated? We found 377 p-values in the 0.01-0.05] interval. In an article reporting a case-control study, the corresponding X i would typically have gured in a table summarizing the single nal model marked with \p-value < 0.05". In reality, only 214 of these 377 p-values corresponded to variables that were actually associated with Y by design. Thus the observed proportion of \signi cant" variables with p-values in the range 0.01-0.05] that were actually associated with Y was only 57%. Thus commonly used interpretations such as \the probability of such a signi cant result occurring by chance is less than 5%" can be misleading when two-step (or stepwise) variable selection is carried out rst; here the empirical probability of such a signi cant result occurring by chance was 43%. Hence the observed proportion of being truly a risk factor for X i when the quoted p-value belongs to 0.01-0.05] is only 57%. One might well have expected a much higher value.
For the two classical methods, the observed proportion was well below 1, and also far below one minus the nominal signi cance level, for p-values in the range .10 right down to .001. Only when the p-value was very small, below .001, was the chance of a false association small and close to its nominal value. The two classical methods gave similar results, although the two-step method had somewhat better performance than the stepwise one. Hence, for 
Bayesian Model Averaging
For the Bayesian approach, we repeated our comparison by recording, among the 6400 posterior probabilities of a variable being a risk factor, Pr( i 6 = 0jD), the ones which led to the declaration of a link between X i and Y, i.e. the Pr( 6 = 0jD) > 50%. To categorize these posterior probabilities, we used the bounds cited in 13] : 50, 75, 95 and 99%, corresponding to weak, positive, strong and very strong evidence for an association with Y. The results are presented in Table 5 . Overall in Table 5 , we see reasonably good agreement between nominal and observed probabilities of an association. The interpretation of the uncertainty concerning the e ect of a potential explanatory variable, quanti ed by its posterior probability Pr( 6 = 0jD) is thus transparent and direct in the Bayesian results, in contrast to that of the p-value given by the classical analyses.
Estimation of the Coe cients
Here we compare the estimation of the logistic regression coe cients, i , given by the di erent methods by summing the squared errors over the 200 simulations:
(where T i is the true value of i in the simulation), calculated separately for the subgroups of variables associated and not associated with Y . The BMA estimate of^ i is given by equation (7). It was not meaningful to evaluate this sum for the stepwise selection method, as^ i is unde ned if X i is not retained in the model. Table 6 contains results for the two-step method and for BMA, for the two di erent simulation setups. For Simulation 1, BMA gives smaller sums of errors for all the types of variables. Hence in smaller studies, where the uncertainty due to model choice is greater, Bayesian estimation via BMA gives an estimate that is closer to the true value on average. In Simulation 2, the mean squared error is smaller, as expected when n increases, and the results of the two methods become closer. The only case where the two-step approach gives a smaller SSE than the Bayesian one is for the variables X 1 ? X 20 , simulated independently from Y, when n = 1; 000. Note that, in this case, the values of Pr( i jD) for such variables are very low, and so these are estimates that one would not usually interpret anyhow. 
Classical analyses
In 9], this dataset was analyzed as matched pairs, considering 35 risk factors classi ed in categories (sexual history, method of contraception, genital infection, risk inducing behavior and demographic characteristics). The authors did not include any interaction terms. First, they performed a univariate analysis for each of the 35 variables, of which 25 had two-sided p-values smaller than .10. In the multivariate analysis, they then constructed meaningful combinations of some of the 35 variables, for example those related to smoking, leaving a total of 28 variables. Of these 28 variables, 18 had two-sided p-values smaller than .10. Starting with these 18 variables, they then carried out a multiple logistic regression based on a stepwise forward analysis. This led to a nal model with 8 variables. Seven of these 8 variables were statistically signi cant at the 5% level, and the eighth, \Years from menarche to rst intercourse", was signi cant only at the 10% level. Because excluding it from the nal subset consistently changed the estimates of most of the seven other logistic coe cients, the authors decided to keep it in their \ nal model", reproduced here in Table 7 . We will do the same in the following classical analysis.
To complete this classical approach, we also ran a stepwise forward analysis starting from all the available variables. Unfortunately, two of them (\estimated number of others partners of current partner", and \douched with water-vinegar, (yes/no)") were no longer available, but these two missing variables had not been statistically signi cant in the univariate analysis 9]. This left a total of 26 available variables. We thus carried out a stepwise procedure starting with all the 26 variables ; this led to 10 of them being included in the nal model, including \Years from menarche to rst intercourse". Table 8 presents the logistic regression coe cients and standard errors estimated in the \ nal" model.
Bayesian Model Averaging
For comparability, we used the same variable de nitions as in 9], we did not consider interactions, and we analyzed the data as matched pairs. The BMA approach starts by considering all possible combinations of the 26 available variables, yielding an initial set of 2 26 models. This is then pared down to the models in Occam's window, namely the most likely model a posteriori and the models whose posterior probabilities are within a factor of 20 of that of the most likely one. To do this, highly unlikely models are rst excluded using the adapted leaps and bounds algorithm as implemented in the bic.logit or bic.glm S-PLUS function (available at www.research.att.com/~volinsky/bma.html or at lib.stat.cmu.edu/S), and then the posterior probabilities of the remaining models are computed using the Laplace approximation, as implemented in the glib S-PLUS function 1 (see Appendix for details). The prior distribution of i is a centered Gaussian distribution whose standard deviation, , was chosen so that the OR between unexposed and exposed subjects would fall in the interval 1/7,7] with prior probability 95%. For a dichotomous variable, this OR is e i , and the interval 1/7,7] corresponds to choosing i N(0,1) a priori. For a continuous exposure variable X i , we chose the prior standard deviation of i so that the OR between subjects at the 25th and 75th percentiles would also fall in the interval 1/7,7] with probability 95%. The resulting prior standard deviations thus depend on the variability, speci cally the interquartile range, of the corresponding continuous variables.
There were 76 models in Occam's window, and these were used to calculate the BMA estimates of the regression coe cients (see the right hand side of Table 8 ). The posterior probability of being a risk factor, given by Pr( i 6 = 0jD), is also shown. Table 8 summarizes the estimation of the logistic coe cients as well as the associated probabilities: the p-values and the Pr( i 6 = 0jD) for the \classical" and Bayesian analyses, respectively. The variables which do not gure in Table 8 had both a nonsigni cant p-value and a posterior probability lower than 5%. We now compare the results of the classical analysis with those of BMA. Six variables had p-values below .01, and these all had posterior probabilities of 100% 2 , so that for these variables the two approaches were in agreement.
Two variables had p-values between .01 and .05. For one of these, the number of genital warts episodes, the posterior probability was 97%, so the two analyses agreed. For the other one, \other cervicitis", the posterior probability was 82%, so that the p-value seems too decisive once model uncertainty is taken into account. An interesting point about the \other cervicitis" variable is that it did not gure in the published results (Table 7) , because the authors initially excluded variables whose p-values was greater than .10 in a univariate analysis, which was the case for \other cervicitis" 3 . Thus it seems that the classical analysis either indicated signi cant evidence for \other cervicitis" being a risk factor, or excluded it completely, depending on the precise methodology used. BMA, on the other hand, consistently indicated positive but not strong evidence for this variable.
The variables that were \not signi cant" in the classical analysis generally had posterior probabilities below 50%, in most cases well below. There was one notable exception, however, namely \gonorrhea or syphilis", whose posterior probability was 66%. Thus the classical analysis missed the (weak) evidence in the data for an e ect of this variable. This high posterior probability seems to indicate that this variable is a good marker of past sexual risk factors. Note nevertheless that only 14% of patients were exposed. In this context of low exposure frequency, the choice of is more in uential and might have contributed to the di erence between classical and Bayesian analyses concerning the selection of this variable.
The only other non-signi cant variable for which the posterior probability approached 50% was \years from menarche to rst intercourse" (39%). Again, BMA gives a more nuanced result than the classical approach, not indicating evidence for this variable but not ruling it out either. If this were an important variable, this result would point towards the need for more research on its possible e ect.
Note that the regression logistic parameter estimates from the Bayesian analysis are shrunk towards zero in comparison with the classical analyses. This is a usual phenomenon in Bayesian estimation and is related to the choice of prior variances for these coe cients which will be discussed later.
DISCUSSION
In observational case-control studies with many potential confounders, it is common to carry out statistical confounder selection using a two-step or stepwise procedure, and then to make inference using the selected model as if standard statistical methods were valid after variable selection. Our simulation study, designed to resemble typical case-control studies, has shown that among variables with a given range of p-values, for example the range .01,.05] commonly declared to be \signi cant", the proportion that actually are risk factors tends to be much lower than one minus the p-value (only 49% actually were risk factors in our simulated case-control studies with 1,000 subjects when stepwise variable selection was used). Thus, commonly made statements such as, \The probability of obtaining such a result by chance is less than one in twenty", are grossly misleading in this context.
If Bonferroni-corrected p-values had been used instead, the correspondence between nominal and observed levels would have been better, but the Bonferroni correction assumes uncorrelated variables and is rarely used in case-control studies. It was not used once in our sample of 49 case-control studies from the AJE.
We have proposed Bayesian model averaging as a formal way of accounting for model uncertainty in case-control studies analyzed using logistic regression. In our simulations, it was well calibrated, unlike the classical p-value methods considered. BMA can be easily implemented, and S-PLUS functions to do it automatically are available on the Web. The posterior probabilities, Pr( i 6 = 0jD), have a clear interpretation, which our simulation suggests is a valid one.
It should be emphasized that BMA is not a substitute for careful incorporation of available scienti c knowledge, or for careful data analysis. These together should lead to a set of candidate confounders, or potential risk factors in a more exploratory study. The role of BMA is merely to account for the uncertainty remaining at the end of the scienti c and data analysis; model uncertainty should be minimized on the basis of scienti c considerations to the extent possible. But the model uncertainty that remains should be taken into account when nal conclusions are drawn.
In any Bayesian analysis, the prior distribution is important. For BMA, there are two major components to the prior distribution. The rst consists of the prior model probabilities, and there we have taken all 2 q models to be equally likely a priori. Our experience has been that the results tend to be relatively insensitive to deviations from this speci cation. There are important ways in which this prior distribution may need to deviate from equiprobability should be noted, following 1]. If a variable C is known from other studies to be undoubtedly related to the disease, and if this association is not subsidiary to a possible exposure/disease association, then C should be included in the model; this can be thought of as assigning prior probability zero to all models that do not include C. Moreover, if a factor is thought to be su ciently important to be used as a matching or balancing factor in the study design, it should be included in all the models considered.
There are various possible ways other than equal probability to assign prior model probabilities. One approach that seems promising is to elicit prior model probabilities from health professionals 32]. In the results reported in 32], this gave better predictive performance than BMA with equal prior model probabilities.
Regression estimates also depend on the prior distribution of i , and more precisely on the prior scale parameter of the centered Normal chosen as a prior distribution in the Bayesian analysis. The choice of determines a prior interval for the quantity of interest (here the OR, for which we have suggested the prior 95% interval 1 /7,7] ). Note that the context can be useful for tuning more precisely to the kind of study at hand. For example, if we regularly observed OR's as high as 14 (instead of 7) for variables in case-control studies similar to the one being analyzed, we might double the value of , yielding a 95% prior interval for the OR of 1/14, 14]. In the cervical cancer application, we tested the in uence of the choice of prior variances by changing these to the ones described above (i.e. OR in the interval 1/14, 14]). The posterior probabilities and estimates of the coe cients were essentially unchanged from these of Table 8 (results not shown).
As a nal comment on the in uence of the prior variance for i , we note that the shrinkage e ect on i induced by the prior distribution of this coe cient is more marked when the maximum likelihood estimate of i is less precise. For example, in our application, this happens for dichotomous variables with low frequency of exposure, such as \Genital warts", \Gonorrhea or syphilis" or \Other cervicitis".
One objection that might be raised against BMA is the following. The view might be taken that the interpretation of an OR depends on the confounders for which it has been adjusted, and hence that BMA, by combining results from models with di erent sets of confounders, is really mixing apples and oranges. We believe that this objection does not apply when the quantity of interest Q in equation (3) has the same interpretation for each model considered. This will be the case if, for example, Q can be interpreted as an observable quantity to be predicted. An adjusted log-odds ratio such as 1 can often be cast in this framework, since it can be thought of as the approximate log-odds ratio in a stratum from a hypothetical future large sample exchangeable with the current one. The relevant stratum would be one de ned by stratifying by all the potential confounders X 2 ; : : : ; X q .
Another way of looking at this issue is as follows. BMA can be thought of as averaging over a collection of models. However, it can also be thought of as carrying out inference based on just one model, the full model with all variables X 1 ; : : : ; X q , but with a rather special prior. This prior assigns non-zero probability to the events f i = 0g for each i, i.e. it allows for the possibility that the coe cients might be zero. Thus, since BMA can be thought of as a way of making Bayesian inference about a single model, the resulting inference about one of its coe cients can be validly interpreted in the usual way. One possible objection to such a prior is that we would never believe that a coe cient could be exactly zero, although we might well expect it to be small. This concern is alleviated by the fact that the results from this prior are very similar to those from a di erent prior in which the probability is spread over a moderately small interval about zero instead of being concentrated precisely at zero; this interval can be as wide as half a standard error 33].
One strong result to emerge from our simulation study is the di culty of interpretation of the p-value in classical stepwise and two-step procedures. A smaller than expected proportion of the variables declared to be associated with the disease outcome, actually are. On the other hand, Bayesian model averaging provides a transparent statement of the probability that a variable is associated with a health outcome, through the posterior probability Pr( i 6 = 0jD).
Such an approach could be helpful with the di cult task of choosing confounders, and was shown to have good performance in a realistic simulation study.
